0.5% Ribavirin Eye Drops 10ml | Broad-Spectrum Antiviral Ophthalmic Solution

Ribavirin Eye Drops
  • Concentration: 0.5% Ribavirin (5 mg/ml)
  • Volume: 5ml or 10ml per bottle
  • Packaging: Sterile plastic dropper bottle, 1 bottle/box
  • Shelf Life: 24 months (unopened)

Click to add this item to cart.

Product Description

Product Name0.5% Ribavirin Eye Drops 10ml (Ribavirin Ophthalmic Solution)
Specification10ml sterile eye drops containing 0.5% (5 mg/mL) Ribavirin
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientRibavirin (Antiviral Agent — Guanosine Analogue)
Pharmacological ClassAntiviral Ophthalmic Agent (Broad-Spectrum Antiviral / Nucleoside Analogue)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 1-2 hours initially, then reduced as directed.
PackagingSterile multi-dose dropper bottle (10ml) with tamper-evident seal
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Shelf Life24 months unopened; discard within 4 weeks of first opening

Product Overview

0.5% Ribavirin Eye Drops is a sterile ophthalmic solution containing 0.5% (5 mg/mL) ribavirin. It is an antiviral eye drop used for the topical management of viral eye infections affecting the ocular surface.

0.5% Ribavirin Eye Drops 10ml: What the Published Guidance Says

Fifteen ophthalmic products spanning anti-infective, anti-allergic, anti-inflammatory, antiviral and ocular-surface categories — including the two anti-infectives the WHO Model List names for conjunctivitis and infectious keratitis.

Buyers usually settle three things before ordering 0.5% Ribavirin Eye Drops 10ml: the pharmacopoeial monograph, the pack configuration, and the documents the destination authority will ask for.

  • Trachoma and endophthalmitis have separate recommendations For trachoma the treatment of choice is a single oral dose of azithromycin, with topical azithromycin or tetracycline also indicated. For bacterial endophthalmitis, the listings for ceftazidime, ceftriaxone and vancomycin were extended to cover it as a first-choice option, with the Committee noting that intravitreal administration requires specialist training and adequate infrastructure. WHO eEML — Ofloxacin (ophthalmological)
  • Evidence for conjunctivitis does not favour one antibiotic over another The Committee noted that topical antibiotics are indicated for moderate to severe infection and can be considered in mild cases, but that available evidence does not make it possible to identify specific, preferred antibiotics for conjunctivitis. It therefore endorsed the existing gentamicin and tetracycline listings rather than picking a winner. WHO eEML — Ofloxacin (ophthalmological)
  • Ofloxacin 0.3% — for keratitis, and extended to conjunctivitis Ofloxacin eye drops 0.3% are listed for infectious keratitis, and in 2021 the Expert Committee recommended expanding the indication to include conjunctivitis. Topical fluoroquinolones are the class the Committee endorsed for infectious keratitis. WHO eEML — Ofloxacin (ophthalmological)

We quote these sources rather than paraphrase them loosely, because the detail matters commercially for 0.5% Ribavirin Eye Drops 10ml. Where your national list differs from the WHO listing, the national list governs what may be supplied and promoted locally.

Ordering Parameters for 0.5% Ribavirin Eye Drops 10ml

Product Name0.5% Ribavirin Eye Drops 10ml (Ribavirin Ophthalmic Solution)
Specification10ml sterile eye drops containing 0.5% (5 mg/mL) Ribavirin
Dosage FormSterile Ophthalmic Solution (Eye Drops — for topical ocular administration)
Active IngredientRibavirin (Antiviral Agent — Guanosine Analogue)
Pharmacological ClassAntiviral Ophthalmic Agent (Broad-Spectrum Antiviral / Nucleoside Analogue)
Route of AdministrationTopical ocular (instilled into the conjunctival sac). Typically 1-2 drops in the affected eye(s) every 1-2 hours initially, then reduced as directed.
StorageStore at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening.
Therapeutic groupOphthalmic — Ophthalmic
ManufacturerSinophare Bio-technology Co., Ltd. (GMP, China)
Documentation suppliedCOA, HPLC/GC data, stability data, dossier package

The same therapeutic range is supplied in several presentations, so one purchase order can cover a mixed requirement: 0.1% Dexamethasone Sodium Phosphate Eye Drops 10mL, 5% Taurine Eye Drops 10mL, 1% Acyclovir Eye Drops 10mL, 0.5% Chloramphenicol Eye Drops 10mL, 0.3% Gentamicin Eye Drops 10mL, 0.5% Hypromellose Eye Drops 10mL, 0.5% Kanamycin Eye Drops 10mL, 2.5% Lincomycin Hydrochloride Eye Drops 10mL.

Pharmacopoeial Standard, Release Testing & COA

Products are manufactured and tested against USP, EP, BP and CP monographs, with incoming raw-material inspection, in-process monitoring and full finished-product testing.

Every batch of 0.5% Ribavirin Eye Drops 10ml is tested to the monograph stated on the purchase order. Where a monograph is silent on the presentation, we agree a written specification with you in advance and reference it on the certificate of analysis.

Standardised GMP production workshops with an independent R&D laboratory and a complete quality-inspection centre.

The quality control package for the marketed pack covers:

  • Testing for assay of the active substance
  • Testing for related substances and impurities
  • Testing for dissolution or release profile (solid oral forms)
  • Testing for uniformity of dosage units
  • Testing for water content and pH where applicable
  • Testing for sterility and bacterial endotoxins (parenterals and ophthalmics)

COA, HPLC and GC data, DMF and dossier packages, plus registration support documents for national marketing-authorisation filings.

Packing, Labelling Languages & Export Paperwork

  • Pack size: Sterile multi-dose dropper bottle (10ml) with tamper-evident seal. Non-standard pack sizes can be quoted against your artwork.
  • Storage: Store at room temperature (15°C-25°C), protected from light. Keep container tightly closed. Do not freeze. Discard within 4 weeks of first opening..
  • Shelf life: 24 months unopened; discard within 4 weeks of first opening. Stability data for the marketed pack is included in the dossier.
  • Labelling: we typeset the carton and leaflet in English, Arabic, French, Russian and Spanish and in any further language your market requires, carrying your own brand where the local rules allow.
  • Export: commercial invoice, packing list, certificate of origin, GMP certificate, COA and the free-sale certificate issued by the country of manufacture whenever your customs or regulator asks for it.

Marketing Authorisation & Tender Support

Documents for 0.5% Ribavirin Eye Drops 10ml are issued by Sinophare Bio-technology Co., Ltd. — DML Number Jin20160068 (medicines) and Jin20160069 (paracetamol API).. Keeping one legal manufacturer across the COA, the GMP certificate and the registration file avoids assessment queries later.

  • Answers to authority questions during assessment, handled by the regulatory contact who prepared the file.
  • Tender and framework documentation, including pre-qualification questionnaires and sample logistics.
  • Artwork and mock-up approval pack, showing the carton, label and leaflet exactly as they will be printed for your market.
  • Batch manufacturing and packaging records released for inspection on request during supplier audits.
  • Re-test or renewal support when the marketing authorisation comes up for variation or renewal.

The context for 0.5% Ribavirin Eye Drops 10ml is its place among ophthalmic preparations used in WHO and MSF eye-care protocols. Listing status informs how programmes specify a product; it is not a substitute for the import licence or marketing authorisation of the destination country.

0.5% Ribavirin Eye Drops 10ml: Common Procurement Questions

What pack size is available for 0.5% Ribavirin Eye Drops 10ml?

This presentation is normally supplied as Sterile multi-dose dropper bottle (10ml) with tamper-evident seal. Where your market requires a different count, bottle or carton, we quote to your artwork and extend the stability file to the new pack.

What documentation comes with a shipment of 0.5% Ribavirin Eye Drops 10ml?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening.

Does the batch documentation for 0.5% Ribavirin Eye Drops 10ml support a registration filing?

Shipments are accompanied by a certificate of analysis covering identification, assay and related substances, together with the marketed-pack stability data and the manufacturing site GMP certificate. Shelf life: 24 months unopened; discard within 4 weeks of first opening. The full CTD dossier and the authority assessment file are supplied as part of a registration order; routine shipments carry the COA and stability data only.

What documentation accompanies an ophthalmic order?

Batch COA covering assay, sterility and preservative content, plus stability data, DMF and dossier packages with registration support documents.

Which ophthalmic anti-infectives are on the WHO Model List?

Gentamicin eye drops 0.3% (for infectious blepharitis) and ofloxacin eye drops 0.3% (infectious keratitis, with the indication extended to conjunctivitis in 2021). Amikacin, kanamycin, netilmicin and tobramycin are specified as therapeutic alternatives to gentamicin.

Products Commonly Ordered with 0.5% Ribavirin Eye Drops 10ml

Browse the full Ophthalmic range; all Ophthalmic; the complete product catalogue.

Request a Quotation for 0.5% Ribavirin Eye Drops 10ml

For tenders and programme supply, send the line item, pack size, quantity and destination for 0.5% Ribavirin Eye Drops 10ml 10ml. We return a quotation with lead time, documentation list and sample availability in one response.

Request a quotation

Sources & Regulatory Notes

Reference information only. The published guidance summarised on this page is quoted for professional and regulatory-context purposes and does not constitute medical advice, a prescribing recommendation or a promotion of any product for a particular indication. Prescribing decisions must follow the approved product information and national treatment guidelines in the market of use.

<< return to products